| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/18/2023 | 558.82% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 07/17/2023 | 158.82% | Chardan Capital | $11 → $11 | Reiterates | Buy → Buy |
| 06/08/2023 | 158.82% | Chardan Capital | $9 → $11 | Maintains | Buy |
| 06/07/2023 | 558.82% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 05/18/2023 | 252.94% | BTIG | → $15 | Initiates Coverage On | → Buy |
| 05/17/2023 | 111.76% | Chardan Capital | → $9 | Reiterates | Buy → Buy |
| 05/16/2023 | 558.82% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 05/10/2023 | 558.82% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 05/03/2023 | 558.82% | EF Hutton | → $28 | Initiates Coverage On | → Buy |
| 03/30/2023 | 111.76% | Chardan Capital | → $9 | Reiterates | → Buy |
| 03/22/2023 | 111.76% | Chardan Capital | → $9 | Reiterates | → Buy |
| 01/26/2023 | 111.76% | Chardan Capital | → $9 | Initiates Coverage On | → Buy |
What is the target price for Coya Therapeutics (COYA)?
The latest price target for Coya Therapeutics (NASDAQ: COYA) was reported by EF Hutton on July 18, 2023. The analyst firm set a price target for $28.00 expecting COYA to rise to within 12 months (a possible 558.82% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Coya Therapeutics (COYA)?
The latest analyst rating for Coya Therapeutics (NASDAQ: COYA) was provided by EF Hutton, and Coya Therapeutics reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Coya Therapeutics (COYA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coya Therapeutics was filed on July 18, 2023 so you should expect the next rating to be made available sometime around July 18, 2024.
Is the Analyst Rating Coya Therapeutics (COYA) correct?
While ratings are subjective and will change, the latest Coya Therapeutics (COYA) rating was a reiterated with a price target of $0.00 to $28.00. The current price Coya Therapeutics (COYA) is trading at is $4.25, which is within the analyst's predicted range.